Literature DB >> 1659319

Nucleoside phosphotransferase activity of human colon carcinoma cytosolic 5'-nucleotidase.

M G Tozzi1, M Camici, R Pesi, S Allegrini, F Sgarrella, P L Ipata.   

Abstract

A cytosolic 5'-nucleotidase, acting preferentially on IMP and GMP, has been isolated from human colon carcinoma extracts. This enzyme activity catalyzes also the transfer of the phosphate group of 5'-nucleoside monophosphates (mainly, 5'-IMP, 5'-GMP, and their deoxycounterparts) to nucleosides (preferentially inosine and deoxyinosine, but also nucleoside analogs, such as 8-azaguanosine and 2',3'-dideoxyinosine). It has been proposed that the enzyme mechanism involves the formation of a phosphorylated enzyme as an intermediate which can transfer the phosphate group either to water or to the nucleoside. The enzyme is activated by some effectors, such as ATP and 2,3-diphosphoglycerate. Results indicate that the effect of these activators is mainly to favor the transfer of the phosphate of the phosphorylated intermediate to the nucleoside (i.e., the nucleoside phosphotransferase activity). This finding is in accordance with previous suggestions that cytosolic 5'-nucleotidase cannot be considered a pure catabolic enzyme.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1659319     DOI: 10.1016/0003-9861(91)90125-3

Source DB:  PubMed          Journal:  Arch Biochem Biophys        ISSN: 0003-9861            Impact factor:   4.013


  14 in total

1.  Leukemia Relapse-Associated Mutation of NT5C2 Gene is Rare in de Novo Acute Leukemias and Solid Tumors.

Authors:  Hye Rim Oh; Youn Jin Choi; Nam Jin Yoo; Sug Hyung Lee
Journal:  Pathol Oncol Res       Date:  2015-08-11       Impact factor: 3.201

Review 2.  5'-Nucleotidase: molecular structure and functional aspects.

Authors:  H Zimmermann
Journal:  Biochem J       Date:  1992-07-15       Impact factor: 3.857

3.  Identification of the nucleotidase responsible for the AMP hydrolysing hyperactivity associated with neurological and developmental disorders.

Authors:  Rossana Pesi; Marcella Camici; Vanna Micheli; Laura Notarantonio; Gabriella Jacomelli; Maria Grazia Tozzi
Journal:  Neurochem Res       Date:  2007-07-06       Impact factor: 3.996

4.  Mechanism of the reaction catalysed by cytosolic 5'-nucleotidase/phosphotransferase: formation of a phosphorylated intermediate.

Authors:  C Baiocchi; R Pesi; M Camici; R Itoh; M Grazi Tozzi
Journal:  Biochem J       Date:  1996-08-01       Impact factor: 3.857

Review 5.  Genetics and mechanisms of NT5C2-driven chemotherapy resistance in relapsed ALL.

Authors:  Chelsea L Dieck; Adolfo Ferrando
Journal:  Blood       Date:  2019-03-25       Impact factor: 22.113

6.  Bovine cytosolic IMP/GMP-specific 5'-nucleotidase: cloning and expression of active enzyme in Escherichia coli.

Authors:  S Allegrini; R Pesi; M G Tozzi; C J Fiol; R B Johnson; S Eriksson
Journal:  Biochem J       Date:  1997-12-01       Impact factor: 3.857

7.  ADNP differentially interact with genes/proteins in correlation with aging: a novel marker for muscle aging.

Authors:  Oxana Kapitansky; Illana Gozes
Journal:  Geroscience       Date:  2019-07-01       Impact factor: 7.713

8.  Phosphorylation of adenosine in renal brush-border membrane vesicles by an exchange reaction catalysed by adenosine kinase.

Authors:  J Sayós; C Solsona; J Mallol; C Lluis; R Franco
Journal:  Biochem J       Date:  1994-02-01       Impact factor: 3.857

9.  Structure and Mechanisms of NT5C2 Mutations Driving Thiopurine Resistance in Relapsed Lymphoblastic Leukemia.

Authors:  Chelsea L Dieck; Gannie Tzoneva; Farhad Forouhar; Zachary Carpenter; Alberto Ambesi-Impiombato; Marta Sánchez-Martín; Renate Kirschner-Schwabe; Scott Lew; Jayaraman Seetharaman; Liang Tong; Adolfo A Ferrando
Journal:  Cancer Cell       Date:  2018-07-09       Impact factor: 31.743

10.  Relapse-specific mutations in NT5C2 in childhood acute lymphoblastic leukemia.

Authors:  Julia A Meyer; Jinhua Wang; Laura E Hogan; Jun J Yang; Smita Dandekar; Jay P Patel; Zuojian Tang; Paul Zumbo; Sheng Li; Jiri Zavadil; Ross L Levine; Timothy Cardozo; Stephen P Hunger; Elizabeth A Raetz; William E Evans; Debra J Morrison; Christopher E Mason; William L Carroll
Journal:  Nat Genet       Date:  2013-02-03       Impact factor: 38.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.